Get the Stockscreener App
1.13
1.74%
-0.02
After Hours:
1.14
0.01
+0.88%
Boundless Bio Inc stock is traded at $1.13, with a volume of 9,810.
It is down -1.74% in the last 24 hours and down -5.83% over the past month.
Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.
See More
Previous Close:
$1.15
Open:
$1.13
24h Volume:
9,810
Relative Volume:
0.06
Market Cap:
$25.30M
Revenue:
-
Net Income/Loss:
$-61.06M
P/E Ratio:
-0.0789
EPS:
-14.3261
Net Cash Flow:
$-59.30M
1W Performance:
-0.88%
1M Performance:
-5.83%
6M Performance:
-34.68%
1Y Performance:
-66.47%
1-Day Range:
$1.13
$1.15
1-Week Range:
$1.10
$1.16
52-Week Range:
$1.00
$4.72
Boundless Bio Inc Stock (BOLD) Company Profile
Name
Boundless Bio Inc
Sector
Industry
Phone
(858) 766-9912
Address
10955 ALEXANDRIA WAY, SAN DIEGO
Compare BOLD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BOLD
Boundless Bio Inc
|
1.13 | 25.74M | 0 | -61.06M | -59.30M | -14.33 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Boundless Bio Inc Stock (BOLD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-02-25 | Initiated | H.C. Wainwright | Buy |
| May-28-25 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Dec-13-24 | Downgrade | Guggenheim | Buy → Neutral |
| Apr-22-24 | Initiated | Guggenheim | Buy |
| Apr-22-24 | Initiated | Leerink Partners | Outperform |
| Apr-22-24 | Initiated | Piper Sandler | Overweight |
View All
Boundless Bio Inc Stock (BOLD) Latest News
Should you avoid Boundless Bio Inc. stock right nowJuly 2025 EndofMonth & Free Community Consensus Stock Picks - khodrobank.com
Tick level data insight on Boundless Bio Inc. volatilityMarket Trend Summary & Consistent Profit Trade Alerts - Newser
Backtesting results for Boundless Bio Inc. trading strategiesJuly 2025 Spike Watch & Weekly Setup with High ROI Potential - Newser
Can Boundless Bio Inc. hit a new high this monthJuly 2025 Spike Watch & Community Consensus Trade Signals - Newser
What’s next for Boundless Bio Inc. stock priceRate Cut & Reliable Breakout Forecasts - Newser
Is Boundless Bio Inc. impacted by rising ratesJuly 2025 Reactions & Weekly High Return Opportunities - khodrobank.com
What is the long term forecast for Boundless Bio Inc. stock2025 AllTime Highs & High Conviction Buy Zone Alerts - khodrobank.com
How institutional ownership impacts Boundless Bio Inc. stock2025 Key Lessons & Fast Gain Stock Tips - Newser
Analyzing drawdowns of Boundless Bio Inc. with statistical toolsPortfolio Update Report & Community Trade Idea Sharing Platform - Newser
Boundless Bio Inc. recovery potential after sell offJuly 2025 Gainers & Stepwise Trade Signal Implementation - Newser
What technical models suggest about Boundless Bio Inc.’s comeback2025 Short Interest & Consistent Profit Alerts - Newser
How to manage a losing position in Boundless Bio Inc.July 2025 Technicals & Fast Moving Stock Watchlists - Newser
Price action breakdown for Boundless Bio Inc.Weekly Trade Analysis & Weekly High Conviction Ideas - Newser
Relative strength of Boundless Bio Inc. in sector analysisOil Prices & Real-Time Stock Entry Alerts - Newser
How hedge fund analytics apply to Boundless Bio Inc. stockWeekly Gains Report & Risk Adjusted Buy/Sell Alerts - Newser
Can machine learning forecast Boundless Bio Inc. recoveryEarnings Summary Report & Risk Managed Investment Signals - Newser
Applying Elliott Wave Theory to Boundless Bio Inc.2025 AllTime Highs & Daily Volume Surge Trade Alerts - Newser
How to track smart money flows in Boundless Bio Inc.July 2025 Review & Technical Pattern Recognition Alerts - Newser
What’s the outlook for Boundless Bio Inc.’s sectorChart Signals & Consistent Income Trade Recommendations - khodrobank.com
Watch for Bullish Crossover in Boundless Bio Inc.Dividend Hike & Risk Adjusted Buy and Sell Alerts - beatles.ru
How to forecast Boundless Bio Inc. trends using time seriesWeekly Volume Report & Smart Money Movement Alerts - Newser
Can Boundless Bio Inc. sustain its profitabilityMarket Sentiment Report & Comprehensive Market Scan Reports - khodrobank.com
Identifying reversal signals in Boundless Bio Inc.Earnings Risk Summary & High Accuracy Buy Signal Tips - Newser
Will Boundless Bio Inc. stock hit new highs in YEARWeekly Market Outlook & Free Community Consensus Stock Picks - khodrobank.com
Using data filters to optimize entry into Boundless Bio Inc.Quarterly Earnings Summary & Stepwise Entry/Exit Trade Alerts - Newser
Applying Wyckoff theory to Boundless Bio Inc. stockWeekly Investment Recap & Capital Efficient Trading Techniques - Newser
Is Boundless Bio Inc. showing signs of accumulationTrade Signal Summary & Free Safe Capital Growth Stock Tips - Newser
Using R and stats models for Boundless Bio Inc. forecastingOptions Play & Long-Term Investment Growth Plans - Newser
Boundless Bio Inc. Shows Support at Fibonacci Level getLinesFromResByArray error: size == 0 - sisaissue.com
Using Ichimoku Cloud for Boundless Bio Inc. technicalsLong Setup & Community Trade Idea Sharing - Newser
Detecting price anomalies in Boundless Bio Inc. with AIQuarterly Earnings Report & Technical Pattern Recognition Alerts - Newser
Boundless Bio Inc Stock (BOLD) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.75%
1.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):